Envestnet Asset Management Inc Ascendis Pharma A/S Transaction History

Envestnet Asset Management Inc

$326 Billion
Q2 2025

A detailed history of Envestnet Asset Management Inc transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Envestnet Asset Management Inc holds 21,730 shares of ASND stock, worth $4.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,730

Previous 11,851 83.36%

Holding current value

$4.46 Million

Previous $1.85 Million 103.03%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	BUY	$137.41 - $179.1 $1.36 Million - $1.77 Million	9,879 Added 83.36%	21,730 $3.75 Million
Q1 2025 Apr 29, 2025	BUY	$119.49 - $168.84 $152,230 - $215,102	1,274 Added 12.05%	11,851 $1.85 Million
Q4 2024 Feb 12, 2025	SELL	$122.0 - $146.6 $214,964 - $258,309	-1,762 Reduced 14.28%	10,577 $1.46 Million
Q3 2024 Nov 06, 2024	BUY	$113.0 - $153.43 $191,196 - $259,603	1,692 Added 15.89%	12,339 $1.84 Million
Q2 2024 Aug 08, 2024	BUY	$121.07 - $153.67 $766,736 - $973,192	6,333 Added 146.8%	10,647 $1.45 Million
Q1 2024 May 13, 2024	BUY	$123.45 - $159.4 $65,058 - $84,003	527 Added 13.92%	4,314 $652,000
Q4 2023 Feb 13, 2024	SELL	$86.1 - $127.36 $245,557 - $363,230	-2,852 Reduced 42.96%	3,787 $476,000
Q3 2023 Nov 13, 2023	BUY	$86.5 - $103.97 $151,980 - $182,675	1,757 Added 35.99%	6,639 $621,000
Q2 2023 Aug 04, 2023	BUY	$69.96 - $97.84 $87,030 - $121,712	1,244 Added 34.19%	4,882 $435,000
Q1 2023 May 11, 2023	BUY	$104.9 - $126.78 $14,161 - $17,115	135 Added 3.85%	3,638 $390,000
Q4 2022 Feb 07, 2023	BUY	$99.42 - $131.97 $27,539 - $36,555	277 Added 8.59%	3,503 $427,000
Q3 2022 Nov 10, 2022	BUY	$84.03 - $110.23 $8,823 - $11,574	105 Added 3.36%	3,226 $333,000
Q2 2022 Aug 03, 2022	BUY	$78.08 - $117.61 $68,320 - $102,908	875 Added 38.96%	3,121 $290,000
Q1 2022 May 04, 2022	BUY	$102.18 - $135.75 $28,814 - $38,281	282 Added 14.36%	2,246 $264,000
Q4 2021 Feb 04, 2022	SELL	$127.1 - $169.66 $1.01 Million - $1.35 Million	-7,963 Reduced 80.22%	1,964 $264,000
Q3 2021 Oct 07, 2021	BUY	$112.67 - $176.92 $21,745 - $34,145	193 Added 1.98%	9,927 $1.58 Million
Q2 2021 Aug 04, 2021	BUY	$121.62 - $145.29 $86,836 - $103,737	714 Added 7.92%	9,734 $1.28 Million
Q1 2021 May 04, 2021	SELL	$124.92 - $173.33 $774,504 - $1.07 Million	-6,200 Reduced 40.74%	9,020 $1.16 Million
Q4 2020 Feb 02, 2021	SELL	$151.2 - $182.76 $189,756 - $229,363	-1,255 Reduced 7.62%	15,220 $2.54 Million
Q3 2020 Oct 09, 2020	SELL	$134.29 - $154.32 $814,603 - $936,105	-6,066 Reduced 26.91%	16,475 $2.54 Million
Q2 2020 Jul 08, 2020	BUY	$110.87 - $156.01 $2.5 Million - $3.52 Million	22,541 New	22,541 $3.33 Million

Others Institutions Holding ASND

# of Institutions

282

Shares Held

59.9M

Call Options Held

217K

Put Options Held

73.3K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $11.5B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Ascendis Pharma A/S Transaction History